Atomistic Insights
ActiveHarnessing Protein Dynamics For Breakthrough Medicines
What it does
Drug discovery teams are stuck with tools that take a year to reveal protein dynamics, missing new medicines. Our proprietary AI platform transforms what takes the status quo a year into just two days—exposing hidden binding sites that traditional methods miss. Founded by PhDs from Georgia Tech, we’re already partnered with one biotech and advancing six more. We are redefining what’s druggable and expanding the frontiers of therapeutic discovery.
Next to it in Healthcare and bio · AI protein dynamics drug discovery
- DeepSeq.AIBerkeley SkyDeck SkyDeck Batch 17
DeepSeq.AI | Transforming AI Drug Discovery Using Hyperscaled Data
- InvitrisY Combinator W23
Creating new protein-based drugs at scale
- OrbionAntler Antler Germany 2024
Orbion helps pharmaceutical and biotech companies accelerate their drug discovery process with its proprietary AI models.
- Great Bay Bio 大湾生物Plug and Play PnP 2025
By utilizing AI and other cutting-edge technologies, GBB aims to address the challenges of long timelines, high costs, and low success rates in drug development.
- Diffuse BioY Combinator W23
Generative AI for protein design
- PolybiomicsPlug and Play PnP 2025
Polybiomics enables simultaneous measurements of multiple cellular features from the same sample in real-time.
- Elnora AI, Inc.Plug and Play PnP 2025
Elnora is an AI co-pilot for biomedical lab protocols that learns from every experiment to accelerate drug discovery.
- CytodymeTechstars TS 2025
Cytodyme